Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 40 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1984 adjusted for splits and dividends. The latest closing stock price for Amgen as of April 26, 2024 is 269.98.
  • The all-time high Amgen stock closing price was 322.05 on February 01, 2024.
  • The Amgen 52-week high stock price is 329.72, which is 22.1% above the current share price.
  • The Amgen 52-week low stock price is 211.71, which is 21.6% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 263.34.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 286.1177 295.0931 322.0533 262.7500 269.9800 -5.53%
2023 244.0907 250.9133 286.2321 209.2555 285.7955 13.47%
2022 232.9374 210.7391 278.4880 205.6045 251.8626 20.43%
2021 211.6785 204.3866 235.4246 184.8859 209.1401 0.87%
2020 205.8976 210.7052 232.1817 161.0761 207.3262 -2.00%
2019 170.1339 164.6019 213.4257 144.8753 211.5564 26.70%
2018 159.2089 147.5667 178.6261 139.4555 166.9779 15.17%
2017 140.5080 122.2625 158.1735 122.2625 144.9822 22.25%
2016 124.9861 125.1258 141.4853 108.9377 118.5961 -7.55%
2015 123.7522 123.8440 138.1737 103.9567 128.2789 3.97%
2014 100.6831 87.9966 132.9450 84.6091 123.3792 42.32%
2013 78.3498 66.5115 89.8206 61.2368 86.6934 34.80%
2012 56.5099 46.9361 67.2725 46.6798 64.3106 36.80%
2011 40.7152 40.2491 47.3973 34.9743 47.0093 18.18%
2010 40.3949 41.8180 44.2993 36.4886 39.7781 -2.95%
2009 39.7892 42.7416 46.6686 32.6847 40.9881 -2.04%
2008 37.0547 33.7643 47.7410 28.9605 41.8431 24.35%
2007 41.9695 49.5596 54.9576 33.6484 33.6484 -32.02%
2006 51.1855 58.2253 58.2253 46.3136 49.4944 -13.38%
2005 50.6823 46.5745 62.4350 41.4446 57.1385 22.93%
2004 42.6767 45.1761 47.9873 38.1841 46.4803 3.82%
2003 44.5158 35.7351 51.8347 35.4163 44.7703 27.82%
2002 35.7871 40.8650 45.2703 22.5120 35.0250 -14.35%
2001 45.1503 45.5601 53.7548 37.3219 40.8939 -11.73%
2000 47.4378 45.6035 56.5154 37.1770 46.3281 6.46%
1999 26.8878 19.4543 47.0092 18.9761 43.5168 129.89%
1998 12.1047 9.7706 19.0015 8.5371 18.9290 93.05%
1997 10.0952 9.8955 12.3863 8.3324 9.8051 -0.46%
1996 10.5783 10.5512 11.7738 9.3285 9.8502 -8.42%
1995 7.3832 5.2756 10.7559 5.1171 10.7559 101.29%
1994 4.3852 4.4487 5.3779 3.2025 5.3435 19.19%
1993 3.8084 6.3959 6.4077 2.8529 4.4831 -29.91%
1992 5.8408 6.7700 7.0417 4.5284 6.3959 -6.77%
1991 4.0917 1.9246 6.8605 1.7434 6.8605 265.06%
1990 1.1926 0.7774 1.9131 0.6755 1.8793 154.10%
1989 0.6619 0.4830 0.9057 0.4811 0.7396 45.19%
1988 0.4616 0.4868 0.5396 0.3887 0.5094 8.87%
1987 0.4866 0.3567 0.6717 0.2453 0.4679 40.89%
1986 0.3053 0.1905 0.4284 0.1887 0.3321 62.95%
1985 0.1158 0.0717 0.2189 0.0697 0.2038 169.93%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $144.489B $28.190B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
Vertex Pharmaceuticals (VRTX) United States $102.789B 29.59
Regeneron Pharmaceuticals (REGN) United States $97.763B 23.70
Bristol Myers Squibb (BMY) United States $90.596B 6.08
CSL (CSLLY) Australia $87.140B 0.00
GSK (GSK) United Kingdom $84.784B 10.63
Gilead Sciences (GILD) United States $81.266B 16.20
Moderna (MRNA) United States $40.654B 0.00
Biogen (BIIB) United States $29.478B 13.50
Argenex SE (ARGX) Netherlands $21.906B 0.00
BioNTech SE (BNTX) Germany $20.613B 21.05
Illumina (ILMN) United States $19.278B 139.14
Genmab (GMAB) Denmark $18.157B 23.27
Alnylam Pharmaceuticals (ALNY) United States $18.100B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.508B 60.87
BeiGene (BGNE) Cayman Islands $14.208B 0.00
Sarepta Therapeutics (SRPT) United States $12.039B 0.00
Incyte (INCY) United States $11.491B 19.10
Exact Sciences (EXAS) United States $10.672B 0.00
Bio-Techne Corp (TECH) United States $9.850B 36.64
QIAGEN (QGEN) Netherlands $9.375B 19.41
Repligen (RGEN) United States $9.250B 95.76
Roivant Sciences (ROIV) United Kingdom $8.768B 0.00
Legend Biotech (LEGN) United States $8.080B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Ascendis Pharma (ASND) Denmark $7.973B 0.00
Viking Therapeutics (VKTX) United States $7.590B 0.00
Intra-Cellular Therapies (ITCI) United States $6.983B 0.00
Exelixis (EXEL) United States $6.937B 36.77
Cytokinetics (CYTK) United States $6.777B 0.00
Vaxcyte (PCVX) United States $6.532B 0.00
Apellis Pharmaceuticals (APLS) United States $5.779B 0.00
Blueprint Medicines (BPMC) United States $5.553B 0.00
Halozyme Therapeutics (HALO) United States $4.887B 15.08
CRISPR Therapeutics AG (CRSP) Switzerland $4.561B 0.00
Krystal Biotech (KRYS) United States $4.439B 0.00
Zealand Pharma (ZLDPF) Denmark $4.439B 0.00
Nuvalent (NUVL) United States $4.233B 0.00
Alkermes (ALKS) Ireland $4.135B 21.82
Immunovant (IMVT) United States $4.032B 0.00
Insmed (INSM) United States $3.702B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.609B 0.00
ImmunityBio (IBRX) United States $3.459B 0.00
Biohaven (BHVN) United States $3.401B 0.00
Axsome Therapeutics (AXSM) United States $3.388B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.309B 0.00
SpringWorks Therapeutics (SWTX) United States $3.261B 0.00
Fortrea Holdings (FTRE) United States $3.249B 0.00
Iovance Biotherapeutics (IOVA) United States $3.223B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.025B 0.00
Amicus Therapeutics (FOLD) United States $3.012B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.890B 0.00
IDEAYA Biosciences (IDYA) United States $2.887B 0.00
Arcellx (ACLX) United States $2.738B 0.00
MorphoSys AG (MOR) Germany $2.731B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.699B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.687B 0.00
Merus (MRUS) Netherlands $2.637B 0.00
Certara (CERT) United States $2.611B 56.21
Janux Therapeutics (JANX) United States $2.433B 0.00
CG Oncology (CGON) United States $2.412B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.294B 0.00
Vericel (VCEL) United States $2.199B 0.00
Arvinas (ARVN) United States $2.159B 0.00
Denali Therapeutics (DNLI) United States $2.132B 0.00
Vera Therapeutics (VERA) United States $2.107B 0.00
Guardant Health (GH) United States $2.089B 0.00
Kymera Therapeutics (KYMR) United States $2.046B 0.00
Celldex Therapeutics (CLDX) United States $2.027B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.000B 0.00
Apogee Therapeutics (APGE) United States $1.968B 0.00
Keros Therapeutics (KROS) United States $1.955B 0.00
Geron (GERN) United States $1.947B 0.00
Intellia Therapeutics (NTLA) United States $1.931B 0.00
Avidity Biosciences (RNA) United States $1.900B 0.00
Galapagos (GLPG) Belgium $1.887B 0.00
Sana Biotechnology (SANA) United States $1.874B 0.00
Structure Therapeutics (GPCR) United States $1.816B 0.00
Twist Bioscience (TWST) United States $1.797B 0.00
Beam Therapeutics (BEAM) United States $1.778B 0.00
NeoGenomics (NEO) United States $1.768B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.748B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.674B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.643B 13.65
Myriad Genetics (MYGN) United States $1.627B 0.00
Bavarian Nordic (BVNRY) Denmark $1.621B 5.32
Inhibrx (INBX) United States $1.616B 0.00
Zai Lab (ZLAB) China $1.562B 0.00
Edgewise Therapeutics (EWTX) United States $1.484B 0.00
ADMA Biologics Inc (ADMA) United States $1.470B 0.00
Dynavax Technologies (DVAX) United States $1.462B 0.00
Kura Oncology (KURA) United States $1.447B 0.00
Neumora Therapeutics (NMRA) United States $1.440B 0.00
Protagonist Therapeutics (PTGX) United States $1.437B 0.00
Morphic Holding (MORF) United States $1.400B 0.00
Gyre Therapeutics (GYRE) United States $1.395B 0.00
ANI Pharmaceuticals (ANIP) United States $1.369B 16.83
Arcus Biosciences (RCUS) United States $1.340B 0.00
Akero Therapeutics (AKRO) United States $1.309B 0.00
Ligand Pharmaceuticals (LGND) United States $1.246B 15.43
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.244B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.237B 0.00
Spyre Therapeutics (SYRE) United States $1.174B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.154B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.154B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.146B 0.00
MannKind (MNKD) United States $1.131B 0.00
Belite Bio (BLTE) United States $1.108B 0.00
Prothena (PRTA) Ireland $1.104B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.102B 0.00
Scholar Rock Holding (SRRK) United States $1.087B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.085B 0.00
AbCellera Biologics (ABCL) Canada $1.063B 0.00
Vir Biotechnology (VIR) United States $1.026B 0.00
Abivax SA (ABVX) France $0.991B 0.00
Liquidia Technologies (LQDA) United States $0.940B 0.00
MiMedx (MDXG) United States $0.922B 208.17
Immunome (IMNM) United States $0.851B 0.00
ALX Oncology Holdings (ALXO) United States $0.844B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.832B 0.00
Cullinan Therapeutics (CGEM) United States $0.829B 0.00
Immatics (IMTX) Germany $0.828B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.805B 0.00
Viridian Therapeutics (VRDN) United States $0.797B 0.00
Tyra Biosciences (TYRA) United States $0.794B 0.00
REGENXBIO (RGNX) United States $0.788B 0.00
89BIO (ETNB) United States $0.786B 0.00
Tango Therapeutics (TNGX) United States $0.782B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.780B 0.00
PureTech Health (PRTC) United States $0.742B 0.00
Cytek Biosciences (CTKB) United States $0.737B 0.00
CARGO Therapeutics (CRGX) United States $0.720B 0.00
Pliant Therapeutics (PLRX) United States $0.717B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.704B 0.00
Mesoblast (MESO) Australia $0.702B 0.00
Pharming Group (PHAR) Netherlands $0.701B 0.00
Praxis Precision Medicines (PRAX) United States $0.700B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.693B 0.00
Kyverna Therapeutics (KYTX) United States $0.687B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.677B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.650B 0.00
EnGene Holdings (ENGN) United States $0.642B 0.00
Disc Medicine (IRON) United States $0.640B 0.00
Dianthus Therapeutics (DNTH) United States $0.616B 0.00
Stoke Therapeutics (STOK) United States $0.609B 0.00
Nurix Therapeutics (NRIX) United States $0.608B 0.00
Aerovate Therapeutics (AVTE) United States $0.601B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.599B 0.00
HilleVax (HLVX) United States $0.598B 0.00
Pharming Group (PHGUF) Netherlands $0.591B 0.00
WAVE Life Sciences (WVE) Singapore $0.580B 0.00
Cogent Biosciences (COGT) United States $0.575B 0.00
Northwest Biotherapeutics (NWBO) United States $0.574B 0.00
Zymeworks (ZYME) United States $0.572B 0.00
Nuvation Bio (NUVB) United States $0.571B 0.00
Cabaletta Bio (CABA) United States $0.570B 0.00
Novavax (NVAX) United States $0.553B 0.00
Olema Pharmaceuticals (OLMA) United States $0.550B 0.00
Mineralys Therapeutics (MLYS) United States $0.548B 0.00
GH Research (GHRS) Ireland $0.546B 0.00
Castle Biosciences (CSTL) United States $0.536B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
ArriVent BioPharma (AVBP) United States $0.520B 0.00
CureVac (CVAC) Germany $0.517B 0.00
Oric Pharmaceuticals (ORIC) United States $0.517B 0.00
Prime Medicine (PRME) United States $0.516B 0.00
AnaptysBio (ANAB) United States $0.516B 0.00
Absci (ABSI) United States $0.504B 0.00
Astria Therapeutics (ATXS) United States $0.504B 0.00
Adlai Nortye (ANL) Cayman Islands $0.497B 0.00
Arbutus Biopharma (ABUS) United States $0.488B 0.00
Allogene Therapeutics (ALLO) United States $0.487B 0.00
Oculis Holding AG (OCS) Switzerland $0.484B 0.00
Applied Therapeutics (APLT) United States $0.483B 0.00
Celcuity (CELC) United States $0.480B 0.00
Shattuck Labs (STTK) United States $0.465B 0.00
Avid Bioservices (CDMO) United States $0.465B 0.00
Humacyte (HUMA) United States $0.464B 0.00
Alector (ALEC) United States $0.461B 0.00
IGM Biosciences (IGMS) United States $0.450B 0.00
Fulcrum Therapeutics (FULC) United States $0.443B 0.00
Fate Therapeutics (FATE) United States $0.440B 0.00
Editas Medicine (EDIT) United States $0.429B 0.00
C4 Therapeutics (CCCC) United States $0.428B 0.00
Third Harmonic Bio (THRD) United States $0.426B 0.00
ACELYRIN, INC (SLRN) United States $0.419B 0.00
Entrada Therapeutics (TRDA) United States $0.415B 0.00
Annexon (ANNX) United States $0.413B 0.00
Travere Therapeutics (TVTX) United States $0.410B 0.00
Voyager Therapeutics (VYGR) United States $0.403B 2.40
MaxCyte (MXCT) United States $0.385B 0.00
Neurogene (NGNE) United States $0.384B 0.00
FibroBiologics (FBLG) United States $0.381B 0.00
ITeos Therapeutics (ITOS) United States $0.380B 0.00
Alto Neuroscience (ANRO) United States $0.380B 0.00
Anika Therapeutics (ANIK) United States $0.380B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.379B 0.00
Adaptive Biotechnologies (ADPT) United States $0.379B 0.00
PepGen (PEPG) United States $0.379B 0.00
Replimune (REPL) United States $0.378B 0.00
Biomea Fusion (BMEA) United States $0.376B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.368B 0.00
Amarin (AMRN) Ireland $0.353B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.351B 0.00
Aura Biosciences (AURA) United States $0.350B 0.00
TScan Therapeutics (TCRX) United States $0.349B 0.00
Precigen (PGEN) United States $0.348B 0.00
Mersana Therapeutics (MRSN) United States $0.346B 0.00
Revance Therapeutics (RVNC) United States $0.343B 0.00
Caribou Biosciences (CRBU) United States $0.340B 0.00
Nkarta (NKTX) United States $0.337B 0.00
Tenaya Therapeutics (TNYA) United States $0.331B 0.00
Rani Therapeutics Holdings (RANI) United States $0.329B 0.00
Urogen Pharma (URGN) United States $0.324B 0.00
Solid Biosciences (SLDB) United States $0.323B 0.00
Jasper Therapeutics (JSPR) United States $0.319B 0.00
Atea Pharmaceuticals (AVIR) United States $0.311B 0.00
Ocugen (OCGN) United States $0.304B 0.00
MeiraGTx Holdings (MGTX) United States $0.302B 0.00
Terns Pharmaceuticals (TERN) United States $0.300B 0.00
Kamada (KMDA) Israel $0.299B 22.61
Nautilus Biotechnology (NAUT) United States $0.295B 0.00
XOMA (XOMA) United States $0.295B 0.00
Contineum Therapeutics (CTNM) United States $0.292B 0.00
Ventyx Biosciences (VTYX) United States $0.286B 0.00
Erasca (ERAS) United States $0.285B 0.00
CorMedix Inc (CRMD) United States $0.284B 0.00
Anavex Life Sciences (AVXL) United States $0.278B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.273B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.271B 0.00
Rapt Therapeutics (RAPT) United States $0.271B 0.00
Werewolf Therapeutics (HOWL) United States $0.269B 0.00
Inozyme Pharma (INZY) United States $0.267B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.262B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.258B 89.60
ChromaDex (CDXC) United States $0.255B 0.00
XBiotech (XBIT) United States $0.250B 0.00
Invivyd (IVVD) United States $0.247B 0.00
Renovaro (RENB) United States $0.244B 0.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Puma Biotechnology (PBYI) United States $0.235B 10.61
Verastem (VSTM) United States $0.233B 0.00
Prima BioMed (IMMP) Australia $0.229B 0.00
AC Immune (ACIU) Switzerland $0.226B 0.00
23andMe Holding (ME) United States $0.222B 0.00
2seventy Bio (TSVT) United States $0.220B 0.00
Coherus BioSciences (CHRS) United States $0.219B 0.00
UniQure (QURE) Netherlands $0.217B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Sutro Biopharma (STRO) United States $0.214B 0.00
Design Therapeutics (DSGN) United States $0.212B 0.00
Opthea (OPT) Australia $0.212B 0.00
Ovid Therapeutics (OVID) United States $0.212B 0.00
Compass Therapeutics (CMPX) United States $0.204B 0.00
G1 Therapeutics (GTHX) United States $0.202B 0.00
Lifecore Biomedical (LFCR) United States $0.201B 0.00
Poseida Therapeutics (PSTX) United States $0.198B 0.00
INmune Bio (INMB) United States $0.197B 0.00
Adverum Biotechnologies (ADVM) United States $0.195B 0.00
Innate Pharma S.A (IPHA) France $0.194B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.192B 0.00
X4 Pharmaceuticals (XFOR) United States $0.190B 0.00
Candel Therapeutics (CADL) United States $0.189B 0.00
Akoya Biosciences (AKYA) United States $0.189B 0.00
Codexis (CDXS) United States $0.186B 0.00
Cardiff Oncology (CRDF) United States $0.178B 0.00
Elevation Oncology (ELEV) United States $0.177B 0.00
Trevi Therapeutics (TRVI) United States $0.175B 0.00
Agenus (AGEN) United States $0.174B 0.00
Alimera Sciences (ALIM) United States $0.173B 0.00
GENFIT S.A (GNFT) France $0.172B 0.00
Adocia (ADOCY) France $0.169B 0.00
Kodiak Sciences (KOD) United States $0.167B 0.00
Inventiva S.A (IVA) France $0.166B 0.00
Compugen (CGEN) Israel $0.165B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.159B 0.00
Greenwich LifeSciences (GLSI) United States $0.159B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.159B 0.00
Skye Bioscience (SKYE) United States $0.159B 0.00
ScPharmaceuticals (SCPH) United States $0.157B 0.00
Zura Bio (ZURA) United States $0.156B 0.00
CervoMed (CRVO) United States $0.154B 0.00
BioStem Technologies (BSEM) $0.153B 0.00
Gossamer Bio (GOSS) United States $0.152B 0.00
Annovis Bio (ANVS) United States $0.150B 0.00
Adicet Bio (ACET) United States $0.149B 0.00
I-Mab (IMAB) China $0.146B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Molecular Partners AG (MOLN) Switzerland $0.141B 0.00
Cellectis S.A (CLLS) France $0.138B 0.00
Syros Pharmaceuticals (SYRS) United States $0.136B 0.00
DBV Technologies S.A (DBVT) France $0.133B 0.00
Omega Therapeutics (OMGA) United States $0.130B 0.00
VistaGen Therapeutics (VTGN) United States $0.127B 0.00
Sagimet Biosciences (SGMT) United States $0.125B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
PDS Biotechnology (PDSB) United States $0.120B 0.00
Repare Therapeutics (RPTX) Canada $0.117B 0.00
Vor Biopharma (VOR) $0.116B 0.00
Nuvectis Pharma (NVCT) United States $0.116B 0.00
Immunic (IMUX) United States $0.114B 0.00
Seer (SEER) United States $0.113B 0.00
Cartesian Therapeutics (RNAC) United States $0.113B 0.00
Seres Therapeutics (MCRB) United States $0.112B 0.00
CytomX Therapeutics (CTMX) United States $0.108B 0.00
ATyr Pharma (LIFE) United States $0.108B 0.00
TELA Bio (TELA) United States $0.108B 0.00
BioAtla (BCAB) United States $0.108B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
Sangamo Therapeutics (SGMO) United States $0.104B 0.00
Rezolute (RZLT) United States $0.104B 0.00
Adagene (ADAG) China $0.104B 0.00
Emergent Biosolutions (EBS) United States $0.102B 0.00
BioHarvest Sciences (CNVCF) Canada $0.102B 0.00
Bluebird Bio (BLUE) United States $0.100B 0.00
Vigil Neuroscience (VIGL) United States $0.097B 0.00
BioXcel Therapeutics (BTAI) United States $0.097B 0.00
DiaMedica Therapeutics (DMAC) United States $0.096B 0.00
IO Biotech (IOBT) Denmark $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.094B 0.00
Elicio Therapeutics (ELTX) United States $0.093B 0.00
Q32 Bio (QTTB) United States $0.092B 0.00
Allakos (ALLK) United States $0.089B 0.00
Genelux (GNLX) United States $0.089B 0.00
BeyondSpring (BYSI) United States $0.088B 0.00
Abeona Therapeutics (ABEO) United States $0.087B 0.00
Curis (CRIS) United States $0.086B 0.00
Galena Biopharma (SLS) United States $0.086B 0.00
Aileron Therapeutics (ALRN) United States $0.085B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.084B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
InflaRx (IFRX) Germany $0.082B 0.00
Oncolytics Biotech (ONCY) Canada $0.081B 0.00
Leap Therapeutics (LPTX) United States $0.081B 0.00
Eton Pharmaceuticals (ETON) United States $0.080B 0.00
HOOKIPA Pharma (HOOK) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.86
Cognition Therapeutics (CGTX) United States $0.075B 0.00
Passage Bio (PASG) United States $0.075B 0.00
Gritstone Bio (GRTS) United States $0.075B 0.00
Connect Biopharma Holdings (CNTB) United States $0.075B 0.00
Affimed (AFMD) Germany $0.074B 0.00
YS Biopharma (YS) China $0.074B 0.00
Athira Pharma (ATHA) United States $0.074B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.073B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.072B 0.00
Elutia (ELUT) United States $0.070B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.070B 0.00
Alpha Teknova (TKNO) United States $0.069B 0.00
Cue Biopharma (CUE) United States $0.069B 0.00
AN2 Therapeutics (ANTX) United States $0.068B 0.00
Instil Bio (TIL) United States $0.068B 0.00
Precision BioSciences (DTIL) United States $0.067B 0.00
Turnstone Biologics (TSBX) United States $0.067B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Equillium (EQ) United States $0.064B 0.00
Ikena Oncology (IKNA) United States $0.063B 0.00
Rallybio (RLYB) United States $0.062B 0.00
Aligos Therapeutics (ALGS) United States $0.062B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.061B 0.00
Celularity (CELU) United States $0.059B 0.00
Cidara Therapeutics (CDTX) United States $0.059B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
Lantern Pharma (LTRN) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Kezar Life Sciences (KZR) United States $0.058B 0.00
CalciMedica (CALC) United States $0.057B 0.00
LENZ Therapeutics (LENZ) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.055B 0.00
HCW Biologics (HCWB) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.055B 0.00
Intensity Therapeutics (INTS) United States $0.054B 0.00
AVROBIO (AVRO) United States $0.053B 0.00
Genenta Science S.p.A (GNTA) Italy $0.053B 0.00
Checkpoint Therapeutics (CKPT) United States $0.051B 0.00
ARCA Biopharma (ABIO) United States $0.050B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.050B 0.00
Prenetics Global (PRE) Cayman Islands $0.045B 0.00
NKGen Biotech (NKGN) United States $0.045B 0.00
Quince Therapeutics (QNCX) United States $0.045B 0.00
Clene (CLNN) United States $0.045B 0.00
Bolt Biotherapeutics (BOLT) United States $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Ocean Biomedical (OCEA) United States $0.043B 0.00
Immuneering (IMRX) United States $0.042B 0.00
Beyond Air (XAIR) United States $0.042B 0.00
Apollomics (APLM) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.042B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Aadi Bioscience (AADI) United States $0.041B 0.00
Carmell (CTCX) United States $0.040B 0.00
Cara Therapeutics (CARA) United States $0.038B 0.00
Ocuphire Pharma (OCUP) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
NextCure (NXTC) United States $0.036B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Eyenovia (EYEN) United States $0.034B 0.00
IN8bio (INAB) United States $0.033B 0.00
Fortress Biotech (FBIO) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Theratechnologies (THTX) Canada $0.031B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Pluri (PLUR) Israel $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Lumos Pharma (LUMO) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.018B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
KALA BIO (KALA) United States $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
ABVC BioPharma (ABVC) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Vaxxinity (VAXX) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Semper Paratus Acquisition (TVGN) United States $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Eterna Therapeutics (ERNA) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
Trevena (TRVN) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Kintara Therapeutics (KTRA) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.30
Artelo Biosciences (ARTL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Biophytis SA (BPTS) France $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00